LPAR1 Antikörper (AA 21-50)
Kurzübersicht für LPAR1 Antikörper (AA 21-50) (ABIN1804965)
Target
Alle LPAR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 21-50
-
Spezifität
- This EDG2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 21-50 amino acids from the N-terminal region of human EDG2.
-
Aufreinigung
- Ammonium sulfate precipitation
-
-
-
-
Applikationshinweise
-
Approved: WB (1:1000)
Not recommended for: IHC-P -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Haltbarkeit
- 6 months
-
-
- LPAR1 (Lysophosphatidic Acid Receptor 1 (LPAR1))
-
Andere Bezeichnung
- LPAR1 / LPA1 / EDG2
-
Hintergrund
-
Name/Gene ID: LPAR1
Subfamily: Lysophospholipid/Lysosphingolipid
Family: GPCR
Synonyms: LPAR1, EDG-2, EDG2, Gpcr26, Rec.1.3, Vzg-1, Ventricular zone gene 1, LPA receptor 1, LPA-1, LPA1, Mrec1.3, VZG1 -
Gen-ID
- 1902
-
UniProt
- Q92633
-
Pathways
- Myometrial Relaxation and Contraction, Smooth Muscle Cell Migration
Target
-